News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Serologicals Corporation (SERO) Release: Upstate Introduces New Red-Shifted KinEASE FP Assays


10/19/2005 5:09:46 PM

ATLANTA--(BUSINESS WIRE)--May 27, 2005--Serologicals Corporation (NASDAQ: SERO) today announced that Upstate Group, its wholly owned subsidiary, has introduced a new red-shifted assay to its fluorescence polarization products platform. Upstate's KinEASE(TM) FP product previously was limited to use with the green-shifted dye fluorescein. The new red-shifted KinEASE(TM) FP assay is farther red on the wavelength spectrum thereby producing even clearer results. The new emissions spectra reduces compound interference issues that tend to occur in the bluer end of the spectrum. It is ideal for in-house use on smaller sample sizes from bench-top plate screening through robotic primary screening. The KinEASE(TM) FP two-plate kits are available for determining the activity of 80 different protein kinases.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES